Home / News
-
-
Ginkgo Bioworks recently announced a $290M Series E financing round from new and prior investors.2019-09-25View More
-
-
HTG Molecular Diagnostics announced recently after the close of the market that it intends to offer an undisclosed amount of its common stock in a public offering.2019-09-25View More
-
-
OncoCyte said recently that it has entered into a definitive agreement to acquire Razor Genomics, which developed and markets a prognostic test to assess risk in early-stage lung cancer patients after surgery.2019-09-25View More
-
-
Microbiology testing and diagnostics firm PathoQuest today announced the closing of an €8 million ($8.9 million) financing round.2019-09-25View More
-
-
Quidel reported after the close of the market Thursday that its second quarter revenues rose 5 percent year over year due primarily to growth in the firm's rapid immunoassay business.2019-09-03View More
-
-
Bio-Rad Laboratories reported after the close of the market Thursday that its second quarter revenues decreased approximately 1 percent year over year.2019-09-03View More
-
-
Coriell Life Sciences and global professional services firm KPMG said today that they have entered into a partnership with to provide pharmacogenomics data to clinicians at the point of care.2019-09-03View More
-
-
Genomenon has entered the Chinese market by forming a partnership with Shanghai Shanyi Biological Technology Co., a provider of sequencing interpretation, variant validation, and other molecular technology services.2019-09-03View More
-
-
Expedeon reported today an 18 percent increase in second quarter revenues driven in part by sales generated by recently acquired reagent maker TGR Biosciences.2019-09-03View More
-
-
Bio-Techne said today that its fiscal 2019 fourth quarter revenues rose 6 percent over fiscal Q4 2018.2019-09-03View More
-
-
Becton Dickinson reported a 2 percent year-over-year increase in its fiscal third quarter revenues today.2019-09-03View More
-
-
Aqualung Therapeutics said on Tuesday that it has been awarded a $225,000 grant from the National Institutes of Health to develop a panel of biomarkers, called CRIT-ICU, for stratifying patients at risk for acute respiratory distress syndrome (ARDS).2019-09-02View More
-
-
Cancer Genetics today reported a 15 percent increase in second quarter revenues on improved performance by its core discovery services operations.2019-09-02View More
-
-
Biotechnology company Freenome and ADC Therapeutics, an oncology drug discovery and development company, announced today that they have signed a biomarker development agreement.2019-09-02View More
-
-
Genomenon has entered the Chinese market by forming a partnership with Shanghai Shanyi Biological Technology Co., a provider of sequencing interpretation, variant validation, and other molecular technology services.2019-09-02View More
-
-
The FDA has cleared Drawbridge Health¡¯s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes, which the company describes as easier and less painful than a hypodermic needle.2019-09-02View More
-
-
Abbott Laboratories could have the golden touch when it comes down to detecting traumatic brain injuries (TBI).2019-09-02View More
-
-
Abbott Laboratories has developed a portable tool to help law enforcement agencies crack down on people driving under the influence. The Abbott Park, IL-based company looks to expand the reach of the diagnostic tool ¨C S..2019-09-02View More
-
-
Roche has expanded the Global Access Program, originally established to increase availability of HIV diagnostics in underserved countries, to include diagnostic tests for tuberculosis, hepatitis, and human papillomavirus (HPV).2019-09-02View More
-
-
10x Genomics is looking to raise up to $100 million in an initial public offering, according to documents filed Monday with the US Securities and Exchange Commission.2019-08-28View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.